LBLTF OTC
Lattice Biologics Ltd.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -99.4%
5Y: -99.8%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$2M
+12.6% ▲
5Y CAGR: +258.0%
Gross Profit
$1M
+8.3% ▲
5Y CAGR: +314.2%
Operating Income
-$336K
+40.5% ▲
Net Income
-$1M
-46.5% ▼
EPS (Diluted)
$-0.01
-34.3% ▼
EBITDA
-$58K
+76.8% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $4M | $3M | $1M | $2M | $2M |
| YoY Growth | +90107.2% | -27.5% | -57.8% | +89.5% | +12.6% |
| Cost of Revenue | $3M | $2M | $614K | $1M | $1M |
| Gross Profit | $817K | $571K | $541K | $943K | $1M |
| Gross Margin | 21.6% | 20.9% | 46.9% | 43.1% | 41.4% |
| R&D Expenses | $101K | $217K | $2K | $6K | $0 |
| SG&A Expenses | $4M | $3M | $2M | $1M | $1M |
| Operating Expenses | $4M | $3M | $2M | $2M | $1M |
| Operating Income | -$3M | -$3M | -$1M | -$565K | -$336K |
| Operating Margin | -91.3% | -94.6% | -115.1% | -25.8% | -13.6% |
| Interest Expense | $1M | $467K | $467K | $544K | $1M |
| Income Before Tax | -$8M | -$2M | -$1M | -$1M | -$1M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$8M | -$2M | -$1M | -$1M | -$1M |
| Net Margin | -207.8% | -55.7% | -106.6% | -46.2% | -60.2% |
| EPS (Diluted) | $-0.16 | $-0.02 | $-0.01 | $-0.01 | $-0.01 |
| EBITDA | -$6M | -$876K | -$563K | -$264K | -$58K |
| Shares Outstanding | 48M | 78M | 93M | 93M | 103M |